This time, our newsletter begins with an article by Joël Doré about new findings that identify how irritable bowel syndrome symptom severity is related to both a higher intake of foods with poor nutritional quality and gut microbiome features.
Next up, Patrice Cani explains to us about Dysosmobacter welbionis, a newly isolated human butyrate-producing bacterium that might counteract some features of obesity. You will also come across an article by Stéphane Schneider discussing new observational findings in Chinese patients with acute ischemic stroke, in which reduced short-chain fatty acid levels are associated with an increased risk of 90-day poor functional outcomes.
Finally, a panel of experts under the auspices of the International Scientific Association for Probiotics and Prebiotics (ISAPP) updates the definition and scope of postbiotics.
The GMFH publishing team